Philips and BG Medicine partner in molecular medicine for early detection and monitoring of diseases

15-Aug-2006

Philips announced that it has reached a development partnership agreement with BG medicine. Under the agreement Philips Research will collaborate with BG Medicine to advance Philips' development of patient-centered diagnostics and personalized medicine. As a further part of this strategic agreement Philips will take a minority stake in BG Medicine.

The Philips-BG Medicine partnership is an extension of Philips' existing molecular medicine research and development efforts. The collaboration gives Philips access to certain BG Medicine proprietary biomarker discovery and validation technologies, and associated services.

Other news from the department business & finance

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 whitepaper
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 whitepaper